AllerGene AI Therapeutics
Pre-clinicalAllerGene AI Therapeutics leads advancements in cell and gene therapies, developing innovative next generation in vivo cellular immunotherapies and advanced therapeutic solutions.
Founded
2020
Focus
Cell & Gene Therapy
About
AllerGene AI Therapeutics leads advancements in cell and gene therapies, developing innovative next generation in vivo cellular immunotherapies and advanced therapeutic solutions.
Company Info
TypePrivate
Founded2020
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile